Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jul
12
2013
Senate Bill Would Increase Pipeline and Hazardous Materials Safety Administration (PHMSA) Budget by Over 12 Percent Barnes & Thornburg LLP
Aug
16
2013
New All Appropriate Inquiries (ASTM) Phase 1 Environmental Site Assessment Standards Endorsed by EPA as Constituting “All Appropriate Inquiries” under Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) Barnes & Thornburg LLP
Jul
3
2018
FDA Issues First Installment Of Guidance On ‘Mitigation Strategies To Protect Food Against Intentional Adulteration’ Rule Barnes & Thornburg LLP
Jun
22
2015
FDA Issues Draft Guidance on Factors to Consider When Making Benefit-Risk Determinations for IDEs Alert Barnes & Thornburg LLP
Nov
16
2015
Will FDA Finally (and Officially) Define “Natural?” Barnes & Thornburg LLP
May
28
2023
New Consumer Product Safety Regulations In The EU Barnes & Thornburg LLP
Apr
21
2020
California Requires COVID-19 Supplemental Paid Sick Leave for Food Sector Workers Barnes & Thornburg LLP
Oct
8
2012
FTC Releases Revised Green Guides Barnes & Thornburg LLP
Mar
9
2013
Enforcement and Reporting Updates for Pipeline Operators Barnes & Thornburg LLP
Apr
25
2013
Update - Comment Deadline Extended for EPA Proposal to Eliminate Startup, Shutdown, and Malfunction Air Emission Exemptions in 36 States Barnes & Thornburg LLP
Jan
10
2022
Will A Starbucks Union Affect Your Morning Cup Of Coffee? Barnes & Thornburg LLP
May
28
2014
Food and Drug Administration (FDA) Issues Draft Guidance on Appropriate Use of Voluntary Consensus Standards in Medical Device Submissions Barnes & Thornburg LLP
Aug
11
2014
FDA Notifies Congress that It Intends to Regulate Laboratory Developed Tests Barnes & Thornburg LLP
Apr
4
2022
SCOTUS Cert Recap: Copyright Act’s Fair Use Defense, ‘Dormant’ Commerce Clause, And Independent And Adequate State Ground Doctrine Barnes & Thornburg LLP
Jan
12
2015
FDA Issues Draft Guidance on Transfer of a 510(k) Clearance Barnes & Thornburg LLP
Oct
3
2019
No Right, Just Rules: Court Lacks Jurisdiction Over Steakhouse Managers’ Claims Barnes & Thornburg LLP
Jul
12
2016
Prison Sentence for Responsible Corporate Actors Upheld Barnes & Thornburg LLP
Aug
12
2016
Draft Guidance on 510(k)s: FDA Issues Guidance on When Medical Device Modifications Require a New 510(k) and on Software Changes [INFOGRAPHICS] Barnes & Thornburg LLP
Nov
18
2016
Lengthy ‘Medical Device Reporting for Manufacturers’ Guidance Issued By FDA Barnes & Thornburg LLP
Dec
16
2016
FDA Describes Policy for Emerging Medical Device Signals in Final Guidance Barnes & Thornburg LLP
Feb
18
2021
Certain Cannabis Workers Are Not Protected by the NLRA Barnes & Thornburg LLP
Nov
21
2017
FDA Issues Draft Guidance on Convening Panels to Review Food Safety Barnes & Thornburg LLP
Mar
23
2012
Intellectual Property Law Alert - Supreme Court Finds Broad Diagnostic Method Is Not Eligible for Patent Protection Barnes & Thornburg LLP
Jul
2
2013
It’s Not Easy Being Green Re: Unions and Environmental Concerns Barnes & Thornburg LLP
Dec
1
2021
CMS Vaccine Mandate Faces Nationwide Preliminary Injunction Barnes & Thornburg LLP
Mar
2
2015
Drones May Soon Take Off in Agriculture Industry Barnes & Thornburg LLP
Jun
17
2015
Federal Circuit Invalidates Sequenom’s Fetal DNA Prenatal Diagnosis Patent as Not Patent Eligible Barnes & Thornburg LLP
Aug
13
2015
New York Federal Court Authorizes Pharmaceutical Firm to Engage in Off-label Promotion Using Certain Specific Information and Statements Alert Barnes & Thornburg LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins